Literature DB >> 14527824

Effect of Praval bhasma (Coral calx), a natural source of rich calcium on bone mineralization in rats.

Prabhakara N Reddy1, M Lakshmana, U Venkatesh Udupa.   

Abstract

Praval bhasma (PB; Coral calx) is a natural source of rich calcium widely used in traditional system of Indian medicine as a supplement in the treatment of variety of bone metabolic disorders associated with calcium deficiency. The present study was designed to investigate the inhibitory effects of Praval bhasma on the progress of bone loss induced by ovariectomy and concurrent calcium deficiency (CD-OVX). Twenty-four female rats were ovariectomized, 12 sham operated, divided into three groups of 12 each, fed on low calcium diet (0.04% Ca) and treated either with vehicle or Praval bhasma (65 mg/kg body weight, twice a day) for 16 weeks. Compared to sham rats, CD-OVX animals showed an increase in urinary excretion of calcium (Ca) and phosphorus (P), decreased femoral weight and density which were significantly reversed in Praval bhasma treated animals. Measurement of cortical bone morphometric indices by CT-scanning technique showed increased medullary width and cross-sectional area, decreased periosteal area (PA), combined cortical thickness (CCT) and cortical area (CA)/periosteal area in CD-OVX animals compared to sham and PB-treated group. Scanning electron microscopy (SEM) study revealed porous and erosive appearance of the distal femur at the epiphysis and reduced Ca:P ratio in CD-OVX animals compared to sham and PB-treated group. Ash weight, percent ash, ash Ca and ash P levels were lower in CD-OVX animals than in sham or PB group. Histological examination of decalcified femurs showed narrowed and disappearance of trabeculae and widened medullary spaces and decreased impact strength as measured by impact test in CD-OVX animals compared to sham and PB-treated group. The present study concludes that Praval bhasma is effective in the prevention of calcium and estrogen deficient bone loss and justify the continuing use of this ayurvedic preparation in traditional system of Indian medicine for management of bone metabolic disorders such as osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527824     DOI: 10.1016/s1043-6618(03)00224-x

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Impaired extracellular matrix structure resulting from malnutrition in ovariectomized mature rats.

Authors:  Thaqif El Khassawna; Wolfgang Böcker; Katharina Brodsky; David Weisweiler; Parameswari Govindarajan; Marian Kampschulte; Ulrich Thormann; Anja Henss; Marcus Rohnke; Natali Bauer; Robert Müller; Andreas Deutsch; Anita Ignatius; Lutz Dürselen; Alexander Langheinrich; Katrin S Lips; Reinhard Schnettler; Christian Heiss
Journal:  Histochem Cell Biol       Date:  2015-07-26       Impact factor: 4.304

Review 2.  Jasada bhasma, a Zinc-Based Ayurvedic Preparation: Contemporary Evidence of Antidiabetic Activity Inspires Development of a Nanomedicine.

Authors:  Rinku D Umrani; Kishore M Paknikar
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-18       Impact factor: 2.629

3.  An ayurvedic proprietary herbal preparation, Calci-7, prevents ovariectomy-induced osteoporosis in rats.

Authors:  Khushboo G Faldu; Harika Duvva; Jigna S Shah; Prabooth V Shah; Snehal S Patel
Journal:  Ayu       Date:  2016 Jul-Dec

4.  Effects of multi-deficiencies-diet on bone parameters of peripheral bone in ovariectomized mature rat.

Authors:  Thaqif El Khassawna; Wolfgang Böcker; Parameswari Govindarajan; Nathalie Schliefke; Britta Hürter; Marian Kampschulte; Gudrun Schlewitz; Volker Alt; Katrin Susanne Lips; Miriam Faulenbach; Henriette Möllmann; Daniel Zahner; Lutz Dürselen; Anita Ignatius; Natali Bauer; Sabine Wenisch; Alexander Claus Langheinrich; Reinhard Schnettler; Christian Heiss
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

Review 5.  Research progress on applications of calcium derived from marine organisms.

Authors:  Yangli Xu; Jian Ye; Deqing Zhou; Laijin Su
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.